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Introduction
Adipogenesis, the differentiation process of adipocytes from 
precursor cells, provides constant renewal of adipocytes and 
contributes to the increase of adipose tissue mass in obesity 
(Camp et al., 2002; Spalding et al., 2008). Many key compo-
nents of adipogenesis-related pathways have been identified 
(Farmer, 2006). These include key transcriptional regulators, 
such as peroxisome proliferator-activated receptor  (PPAR) 
and CCAAT/enhancer-binding protein  (C/EBP), adipocyte-
specific secretory proteins, such as adiponectin (AdipoQ), and 
lipolysis regulators, such as perilipin A and hormone-sensitive 
lipase (HSL). Temporal studies based on population-averaged 
measurements,  such  as  mRNA  microarrays  (Soukas  et  al., 
2001; Ross et al., 2002), Western blots (Fig. 1 a; Park et al., 
2004), and quantitative PCR (Fu et al., 2005), indicate that the 
expression levels of these molecules increase monotonically 
during adipogenesis.
However,  significant  cell  to  cell  variability  in  cellular 
morphology and lipid accumulation has long been observed for 
differentiating preadipocytes (Green and Kehinde, 1975; Nan   
et al., 2003; Nagayama et al., 2007). Although recent studies 
have further demonstrated that these heterogeneous cells have 
distinct signaling responses to hormonal and growth factor per-
turbations (Shigematsu et al., 2001; Le and Cheng, 2009), it is 
unknown to what extent the observed heterogeneity simply   
reflects stochastic phenotypic variation or the presence of mul-
tiple distinct physiological states. Furthermore, the degree to 
which individual differentiating preadipocytes follow population- 
averaged trends in expression levels or respond differently to 
other important metabolic or pharmacological perturbations is 
unclear. Better characterization of heterogeneity in adipogenesis 
may reveal novel molecular states and subpopulation-specific 
responses to external perturbations that were missed in previous 
population-averaged studies.
  I
ncreases in key components of adipogenesis and li-
polysis pathways correlate at the population-averaged 
level during adipogenesis. However, differentiating pre-
adipocytes are highly heterogeneous in cellular and lipid 
droplet (LD) morphologies, and the degree to which indi-
vidual cells follow population-averaged trends is unclear. 
In this study, we analyze the molecular heterogeneity 
of  differentiating  3T3-L1  preadipocytes  using  immuno-
fluorescence microscopy. Unexpectedly, we only observe a 
small percentage of cells with high simultaneous expres-
sion of markers for adipogenesis (peroxisome proliferator-
activated receptor  [PPAR], CCAAT/enhancer-binding 
protein  ,  and  adiponectin)  and  lipid  accumulation 
(hormone-sensitive lipase, perilipin A, and LDs). Instead, 
we identify subpopulations of cells with negatively corre-
lated expressions of these readouts. Acute perturbation of 
adipocyte differentiation with PPAR agonists, forskolin, 
and  fatty  acids  induced  subpopulation-specific  effects, 
including redistribution of the percentage of cells in ob-
served subpopulations and differential expression levels 
of PPAR. Collectively, our results suggested that hetero-
geneity observed during 3T3-L1 adipogenesis reflects a 
dynamic  mixture  of  subpopulations  with  distinct  physi-
ological states.
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to their respective median values obtained from the quiescent 
subpopulation. Hereafter, we simply refer to these ratios as the 
marker levels.
At  the  population-averaged  level,  AdipoQ,  LDs,  and 
PPAR all increased monotonically from D0 to 12, although some 
degree of variation in initiation times and slopes was observed 
(Fig. 1, a and c). In previous studies, similar temporal trends 
were also observed, although PPAR was seen to plateau even-
tually  (or  even  slightly  decrease)  earlier  than  other  markers 
(Park et al., 2004; Fu et al., 2005). This difference may be be-
cause of differences in differentiation rates or culture condi-
tions. In any case, within the time window of our observations, 
these  population-averaged  measurements  suggested  that  our 
tested markers were positively correlated to LDs (Fig. 1 c).
Characterization of 3T3-L1 adipogenesis 
heterogeneity
On individual differentiating 3T3-L1 cells, the levels of AdipoQ, 
LD, and PPAR were visibly heterogeneous (Fig. 1 b). To char-
acterize the observed heterogeneity, we chose to focus on Adi-
poQ and LD, which are regulated either directly (Iwaki et al., 
2003) or indirectly by PPAR (Fig. 2 a). We used a Gaussian 
mixture model (Slack et al., 2008; Wang et al., 2008) to auto-
matically cluster differentiating (i.e., nonquiescent) 3T3-L1 cells 
from D6 to 12 into subpopulations with similar AdipoQ and LD 
levels (see Materials and methods). We chose to use four sub-
populations, as this number both provided a good fit to our data 
(Fig. S1 a) and reduced the risks of data overfitting. Similar con-
clusions in our subsequent analyses would have been obtained 
with five or six subpopulations (unpublished data).
In this study, we applied high content image analysis 
(Perlman et al., 2004; Loo et al., 2007; Slack et al., 2008) to 
model  the  heterogeneity  observed  during  adipogenesis  of 
3T3-L1 preadipocytes as a mixture of phenotypically distinct 
subpopulations. We then used this decomposition to investigate 
the dynamics and molecular changes that occur during adipo-
genesis. Finally, we characterized redistributions and changes 
to the subpopulations in response to pharmacological and 
metabolic perturbations.
Results and discussion
3T3-L1 adipogenesis at the population-
averaged level
3T3-L1 cells were fixed on days 3 (D3), 6, 9, and 12 after induc-
tion of differentiation (Fig. 1 b) and were costained with a DNA 
marker and the adipogenesis markers AdipoQ (Scherer et al., 
1995), PPAR (Tontonoz et al., 1994), and lipid droplets (LDs; 
an essential readout for adipocyte maturation). As expected, ac-
cumulations of these adipogenesis markers were observed after 
D3. A subpopulation of fibroblast-like quiescent 3T3-L1 cells, 
with background levels of staining for these adipogenesis mark-
ers, remained throughout the observation period.
We next quantified changes in marker intensities. First, 
individual cells were automatically identified (Loo et al., 2007) 
and manually annotated as either differentiating or quiescent 
(see Materials and methods). Next, for each cell, we measured 
the averaged cellular levels of AdipoQ and LDs and the aver-
aged nuclear level of PPAR. Finally, for each differentiating 
cell, the three averaged marker levels were normalized as ratios 
Figure  1.  Population-averaged  levels  of 
adipocyte markers increased monotonically on 
differentiating 3T3-L1 preadipocytes. (a) West-
ern blots of differentiating 3T3-L1 cells probed 
with antibodies for AdipoQ, PPAR, and HSL. 
Equal amounts of proteins were collected from 
each day of differentiation. For AdipoQ, only 
the tetramer bands are shown (D0, right before 
differentiation induction; D3–12, D3–12 after 
differentiation induction). (b) Bright field differ-
ential interference contrast and immunofluores-
cence images showing differentiating 3T3-L1 
cells.  For  visualization  only,  marker  intensity   
ranges  were  equalized  across  all  images.   
(c)  Comparisons  of  marker  levels  obtained 
from  Western  blots  and  median  cell  expres-
sion values from immunofluorescence images 
(see Materials and methods). Each graph was 
normalized to have unit sum across all days. 
Bar, 150 µm.377 Heterogeneity in 3T3-L1 adipogenesis • Loo et al.
unexpected states with negatively correlated levels of AdipoQ 
and LDs. Interestingly, negative correlations were also observed 
in vivo between the serum level of AdipoQ and body mass in-
dex (Arita et al., 1999) or overexpression of AdipoQ and adi-
pose tissue mass (Bauche et al., 2007).
Temporal sequence of the identified 
subpopulations
Because of the differences in LD levels among the identified 
subpopulations, we hypothesized that these subpopulations might 
correspond to different stages of adipogenesis. To test this hypoth-
esis, we measured the distribution of different subpopulations 
from D3 to 12 on fixed cells (Fig. 3 a). Our results showed that 
subpopulations with higher LD levels were enriched toward the 
end of adipogenesis and were thus likely to represent cells at 
later stages of adipogenesis. However, this analysis based on fixed 
cells was insufficient to determine whether S3 and S4 corre-
sponded to stages on the same or different differentiation paths.
To determine qualitatively the temporal occurrence of the 
identified subpopulations, we used phase contrast microscopy 
to track the cellular and lipid morphologies of live differentiat-
ing 3T3-L1 cells for 18 d (Fig. 3 b and Video 1). Only cells with 
significant lipid accumulations were tracked. Similar to previ-
ous studies, we found that most tracked cells progressed through 
a stereotyped series of phenotypic changes (Fig. 3 b and Video 1; 
Cells near the centroids of the identified subpopulations 
exhibited visually distinct phenotypes (Fig. 2 b). We denoted the 
subpopulations as S1–4, ranked by the increasing average LD 
levels of the subpopulations (Fig. 2 c). To test the degree to which 
these subpopulations represented stable phenotypes, we mea-
sured the changes in subpopulation-averaged AdipoQ and LD 
levels between D9 and 12 (Fig. S1 b). We did not analyze earlier 
time points because most cells in earlier time points were in S1. 
Although the fractions of the identified subpopulations varied 
between D9 and 12 (Fig. S1 c), we found that the subpopulation-
averaged LD level itself did not change significantly in any sub-
population (Fig. S1 b). Similar results were obtained for AdipoQ 
except for S2. These results suggested that the identified subpop-
ulations corresponded to distinct and stable phenotypic states.
Surprisingly, there was only a small percentage of cells 
with both extremely high AdipoQ and LD levels (Fig. 2, c and d). 
In particular, S3 cells had higher AdipoQ levels but lower   
LD levels, whereas S4 cells had lower AdipoQ levels but higher 
LD levels. Similar differences were also observed for PPAR 
(Fig. 2 e). The existence of S3 and S4 cells was not obvious 
from population-averaged measurements (Fig. 1 a) or from sub-
population characterizations based only on lipid accumulation 
(Lee et al., 2004; Le and Cheng, 2009). Thus, our characteriza-
tion of adipogenesis heterogeneity excluded an expected mo-
lecular state with high AdipoQ and LD levels and revealed two 
Figure  2.  Automated  clustering  identified   
differentiating 3T3-L1 subpopulations with distinct 
phenotypes. (a) AdipoQ and LDs were chosen as 
downstream readouts of PPAR. (b) Differentiating 
3T3-L1 cells from D6–12 (Fig. S1 c) were com-
putationally pooled and clustered based on their 
AdipoQ and LD levels. Four subpopulations were 
identified (S1–4). The subpopulation of quiescent 
cells (S0) was excluded before clustering. Immuno-
fluorescence images of two cells near the centroid 
of  each  subpopulation  are  shown.  White  lines 
indicate cell segmentation boundaries. (c) Scatter 
plot and 2D histogram showing the distribution of 
3T3-L1 cells on D9. Triangles indicate centroids 
for S1–4 in the original subpopulation model. 
(d) Venn diagram showing the overlap of 3T3-L1 cells 
with high AdipoQ or LD levels. (e) Subpopulation-
averaged levels of PPAR. Error bars indicate SEM 
(n = 3); **, P < 0.01 by two-tailed paired t test. 
Bar, 20 µm.JCB • VOLUME 187 • NUMBER 3 • 2009   378
misrepresent cellular states of single cells and why cells with 
widely  varying  lipid  accumulations  were  observed  within 
each of our time points (Fig. 1 b and Fig. 3 a). The dwell times 
of ≥1–2 d for differentiating 3T3-L1 cells in these identifiable 
stages accounted for our ability to identify distinct states within 
the fixed cell data (Fig. 2 b and Fig. S1 b). In summary, both the 
fixed and live cell results supported the hypothesis that the iden-
tified subpopulations represented different stages of adipogene-
sis ordered in time from S1 to S4. The last subpopulation, S4, 
likely corresponded to the terminally differentiated state.
Molecular profiles of the subpopulations
To better understand the molecular states of the identified sub-
populations, we investigated the expression levels of additional 
components of adipogenesis-related pathways, namely C/EBP, 
perilipin A, total HSL, and inactive phospho-HSL (pHSL; phos-
phorylated at Ser565; Strålfors et al., 1984). In new replicate 
experiments, we costained cells with markers for DNA, LDs, 
AdipoQ, and one of the aforementioned molecules and used the 
Nan et al., 2003; Nagayama et al., 2007). We manually assigned 
each time point in the captured live cell sequences to a subpopu-
lation based on cellular and LD morphology (Fig. 3, b and c; and 
Table S1). Most of the cells exhibited temporal changes in cellu-
lar morphology following the same order of lipid accumulation as 
in S1–4 (Fig. 3 d). Importantly, the reductions in cytosolic re-
gions (S4 phenotypes) were almost always preceded by accumu-
lations of large numbers of tiny LDs (S3 phenotypes), suggesting 
that S3 and S4 were subsequent stages on the same differentiation 
path (Fig. 3, b–d; and Video 1). For several of our tracked cells, 
LDs began to shrink in size after the cells were in S4, and in some 
cases, the LDs even vanished entirely (Fig. 3 d and Video 1).
Previous studies have shown that 3T3-L1 preadipocytes 
synchronously enter into mitotic clonal expansion upon uniform 
induction of differentiation (Gratzner et al., 1985; Tang et al., 
2003), yet the subsequent time of appearance for lipid accu-
mulations can be highly variable (Fig. 3 d; Nan et al., 2003; 
Nagayama et al., 2007). This heterogeneity provided a plausible 
explanation as to why population-averaged measurements could 
Figure 3.  Temporal ordering of the identified 3T3-L1 subpopulations. (a) Changes in the percentages of subpopulations from D3–12. (b) Differentiating 
3T3-L1 cells with visible lipid accumulations were tracked for 18 d using live cell phase contrast microscopy. Significant cell morphological changes for 
one of the 40 tracked cells are shown. Time-lapse videos for this and two other cells are shown in Video 1. (c) Examples of fixed 3T3-L1 cells in differen-
tial interference contrast (top) and immunofluorescence (bottom) from D6 to 12 that appeared similar to the cell tracked in b. (d) Bar chart showing the 
subpopulation assignments for all 40 tracked live cell sequences. Triangles indicate cells shown in Video 1. “Lost” refers to cells that either lost their LDs or 
disappeared from our view. Error bars indicate SEM (n = 3). Bars, 20 µm.379 Heterogeneity in 3T3-L1 adipogenesis • Loo et al.
perturbations might affect the distribution of the identified 3T3-L1 
subpopulations. We used three classes of perturbations: PPAR 
agonists, cAMP-elevating agents, and fatty acids. To character-
ize acute effects, we applied these perturbations for only 24 h 
on D8 and measured changes in the population-averaged and 
subpopulation-averaged marker levels. We also tested whether 
these perturbations induced significant numbers of cells with 
new phenotypes that were not modeled by our subpopulation 
model (see Materials and methods). Under the control condi-
tions, only 4–5% of all cells were detected as having new pheno-
types. Thus, for each subpopulation, we deemed an absolute 
change in the percentage of cells as significant when the abso-
lute change was >5% of all cells.
Effects of PPAR agonists
First, we examined the effects of three structurally dissimilar 
PPAR agonists: thiazolidinedione-based troglitazone and rosi-
glitazone and non–thiazolidinedione-based GW1929. All three 
PPAR agonists increase the expressions of most PPAR down-
stream targets, including AdipoQ (Iwaki et al., 2003). As ex-
pected, at the population-averaged level, these drugs significantly 
increased AdipoQ and LD levels but did not significantly change 
PPAR levels (Fig. 5 a). Based on these results, one might ex-
pect that PPAR agonists would have no effect on PPAR levels 
for all subpopulations, increase the percentages of both S3 and 
S4, and/or induce a new subpopulation with both high AdipoQ 
and LD levels.
existing subpopulation model to cluster cells into the four sub-
populations. For this and subsequent experiments, we focused 
on D9, as this day provided reasonable representation for each 
of the identified subpopulations (Fig. 3 a) and was commonly 
used for metabolic studies.
For S1, we found relatively high total HSL but low inactive 
pHSL levels (Fig. 4), which is consistent with a previous observa-
tion showing that lipase activity was significantly elevated during 
early stages of adipogenesis (Kawamura et al., 1981). On S2, 
although LDs showed little expression, PPAR and AdipoQ 
showed clear signs of activation. The presence of a subpopulation 
of 3T3-L1 cells with a relatively high PPAR level but low LD 
level was recently reported (Le and Cheng, 2009). Importantly, we 
found that the adipogenesis regulators (PPAR and C/EBP) 
peaked on S3 cells, whereas the lipolysis regulators (HSL, pHSL, 
and perilipin A) peaked on S4 cells (Fig. 4). Thus, the negative cor-
relations observed between AdipoQ and LD levels for S3 and S4 
extended to a larger set of lipolysis and adipogenesis pathway com-
ponents. These distinct molecular signatures further confirmed 
our observation that these subpopulations were in distinct physio-
logical states of adipogenesis.
Perturbing 3T3-L1 subpopulations during 
adipogenesis
PPAR and LDs are direct or indirect targets of many important 
pharmacological and metabolic perturbations that affect adipo-
genesis and lipid metabolism. We wondered whether these 
Figure 4.  Profiles of the 3T3-L1 subpopula-
tions were extended to include additional key 
components of the adipogenesis and lipolysis 
pathways.  (a)  Heat  map  showing  normal-
ized  levels  of  additional  markers  for  each 
subpopulation. Marker levels were scaled to 
their maximum values across all subpopula-
tions.  Rows  were  hierarchically  clustered.   
(b) Pairwise statistical comparisons of marker 
levels between S4 and all other subpopulations. 
Error bars indicate SEM (n = 3); *, P < 0.05; 
**, P < 0.01; ***, P < 0.001 by two-tailed 
paired t test.JCB • VOLUME 187 • NUMBER 3 • 2009   380
include smaller sizes of LDs, higher expressions of AdipoQ, and 
increased cell numbers in response to PPAR agonists. An inter-
esting hypothesis is that the adipocytes observed in vivo are 
newly differentiated cells (Okuno et al., 1998), which would be 
consistent with an interpretation of our data that PPAR agonists 
increase the rate of new adipocytes transitioning from S2 to S3.
Effects of cAMP-elevating agent
Second, we studied how a cAMP-elevating agent, forskolin, 
affected adipogenesis. Elevation of cAMP levels can have op-
posing effects on lipid accumulation. On one hand, adipogenesis 
is known to be enhanced by cAMP-elevating agents (Farmer, 
2006); on the other hand, elevated cAMP levels can also cause 
HSL-mediated lipolysis of LDs (Egan et al., 1992). We were in-
terested to observe how these two opposing effects were mani-
fested at the subpopulation level.
At the population-averaged level, we found that forskolin 
significantly reduced the LD level (Fig. 5 d, column 1). How-
ever, at the subpopulation level, forskolin only decreased the per-
centage of S4 cells but not S3 cells (Fig. 5 d, column 5). This result 
However,  characterization  at  the  subpopulation  level 
revealed that PPAR agonists increased the average PPAR 
levels of both S3 and S4 cells (Fig. 5 c). Interestingly, the per-
centage of S3 cells was increased without significantly affecting 
their average AdipoQ and LD levels. In contrast, the percentage 
of S4 cells remained unaffected, but their average AdipoQ and 
LD levels were increased (Fig. 5, b and d). Neither rosiglitazone 
nor GW1929 induced significant new subpopulations, although 
troglitazone did induce a new, but small (11%), subpopula-
tion (Fig. 5 b). Together, these results suggested that differenti-
ating 3T3-L1 cells responded heterogeneously to acute treatment 
with PPAR agonists. Furthermore, the negative correlation 
between AdipoQ and LDs remained true even after stimulation 
with PPAR agonists (Fig. 5 b).
Furthermore, our characterization of the effects of PPAR 
agonists revealed that S3 recapitulated many key phenotypes 
of a curious subpopulation of adipocytes that were observed 
in vivo and suggested to play a role in PPAR agonist–induced 
improvement in insulin sensitivity (Hallakou et al., 1997; Okuno   
et al., 1998; Yamauchi et al., 2001). The phenotypic similarities 
Figure  5.  Differentiating  3T3-L1  cells  re-
sponded  heterogeneously  to  external  per-
turbations.  Differentiating  3T3-L1  cells  were 
treated with pharmacological and metabolic 
perturbations for 24 h on D8. (a–c) The effects 
of either DMSO control or 10 µM troglitazone, 
as measured by population-averaged marker 
levels  (a),  2D  histograms  of  cell  densities 
(b; triangles indicate centroids for S1–4 in the 
original  subpopulation  model;  Snew  indicates 
cells with previously unobserved phenotypes), 
and subpopulation-averaged PPAR levels (c), 
are shown. (d) The effects of 12 perturbations 
were measured by absolute changes in popu-
lation-  and  subpopulation-averaged  marker 
levels  and  subpopulation  distributions.  Each 
perturbation had at least three replicates and 
300 cells per replicate. (e) PPAR levels in S4 
versus  PPAR-binding  abilities  for  the  tested 
fatty acids and 15-d-PGJ2. Palmitic acid had 
a half-maximal inhibitory concentration value 
>30 µM and thus was excluded (, Pearson’s 
correlation  coefficient).  Error  bars  indicate 
SEM (n = 3); *, P < 0.05; **, P < 0.01; ***, 
P < 0.001 by two-tailed t test.381 Heterogeneity in 3T3-L1 adipogenesis • Loo et al.
of underlying biological processes (Elowitz et al., 2002; Geva-
Zatorsky et al., 2006) as well as asynchrony of differentiation 
processes. In this study, we found that this heterogeneity also 
reflects the presence of a dynamically evolving mixture of pheno-
typically distinct subpopulations. This finding was consistent 
with the hypothesis that differentiating cells transit through 
multiple robust and discrete phenotypic states (Waddington, 1957; 
Huang and Ingber, 2006–2007).
Our  decomposition  of  heterogeneity  provided  new  in-
sights into the process of 3T3-L1 adipogenesis that were masked 
by population-averaged assays. In theory, correlated increases 
in readouts at the population-averaged level could be caused by 
correlated increases at the single-cell level. However, we found 
that AdipoQ and LD were negatively correlated in later stages 
of adipogenesis. Future studies with finer temporal resolution 
and additional markers may refine our characterization of the 
identified  subpopulations  and  their  physiological  states. The 
elucidation of cellular states and dynamics during differentia-
tion will improve our understanding of mechanisms underlying 
adipogenesis and help in the design of better therapeutic strate-
gies for targeting specific subpopulations.
Materials and methods
Cell culture and differentiation
3T3-L1 mouse preadipocytes were obtained from American Type Culture 
Collection (CL-173; lot 4715281) and propagated in Dulbecco’s minimum 
essential medium with 4 g/liter glucose and 10% bovine calf serum (Hy-
clone). Cells were regularly subcultured before reaching 70% confluence, 
and the passage number was kept at less than six. 3T3-L1 cells were differ-
entiated according to standard methods (Sadowski et al., 1992; Engelman 
et al., 1999). In brief, 3T3-L1 preadipocytes were plated to a 100-mm cul-
ture dish at a very high density (3–4 million in 20 ml medium) and incu-
bated overnight. On the next day (D0), the medium was gently replaced 
with  stage  I  differentiation  medium  of  Dulbecco’s  minimum  essential   
medium (glucose content 4 g/liter) supplemented with 10% FBS (Gemini 
Bio-Products), 160 nM insulin (Sigma-Aldrich), 250 nM dexamethasone 
(Sigma-Aldrich), and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich). 
The medium was renewed once on D2. On D3, the medium was switched 
to stage II differentiation medium of Dulbecco’s minimum essential medium 
with 10% FBS and 160 nM insulin. On D5, the medium was changed to 
adipocyte maintenance medium of Dulbecco’s minimum essential medium 
with 10% FBS supplement and was renewed every other day.
For fixed-cell assays, 40 h before fixation, differentiating cells were 
harvested and transferred to 384-well glass-bottom imaging plates (Thermo 
Fisher Scientific) pretreated with 0.01% sterile poly-L-lysine solution (molec-
ular mass of 70,000–150,000 D; Sigma-Aldrich). Cells were gently 
washed with PBS and detached with 10 min trypsin EDTA treatment at 
room temperature. The detached cells were spun down by centrifugation at 
900 rpm and suspended in low glucose adipocyte maintenance medium 
(Dulbecco’s minimum essential medium with 1 g/liter glucose and 10% FBS 
supplement) before being mixed and transferred to the imaging plates by 
hand pipetting. The optimal cell density was 7,000 cells at 50 µl in each 
well. Cells were settled to the bottoms of plates by centrifugation at 200 
rpm for 2 min. After overnight incubation, cells were starved in defined 
Dulbecco’s minimum essential medium with 1 g/liter glucose and 0.5% 
wt/vol BSA (fatty acid free; Gemini Bio-Products) for 24 h. For live cell assays, 
3T3-L1 cells were subcultured and differentiated directly onto 96-well glass-
bottom imaging plates (Thermo Fisher Scientific).
Drug and fatty acid treatment
The  stock  solutions  of  troglitazone,  rosiglitazone,  15-d-PGJ2  (Cayman 
Chemical), GW 1929 (Enzo Life Sciences, Inc.), and forskolin (Sigma- 
Aldrich) were prepared either in water or DMSO depending on their stabil-
ity  and  solubility.  The  BSA-bound  stocks  of  palmitic,  palmitoleic,  oleic, 
linoleic, -linolenic, arachidonic, and eicosapentaenoic acids (Sigma- 
Aldrich) were prepared as 5 or 10 mM according to their solubility (Hannah 
et al., 2001). In brief, free fatty acids (FFAs) were dissolved with ethanol in 
suggested that forskolin did not stimulate hydrolysis equally 
for cells in different stages of adipogenesis, which is consistent 
with previous studies showing that adipocytes with larger LDs 
(S4 phenotypes) had higher lipolytic sensitivity than adipocytes 
with smaller LDs (S3 phenotypes; Smith et al., 1974; Arner and 
Ostman, 1978).
Forskolin increased the population-averaged PPAR level 
(Fig. 5 d, column 1). However, unlike forskolin’s subpopulation-
specific effects on LDs, the PPAR levels of all subpopula-
tions were significantly increased (Fig. 5 d, column 5), even 
on S1 and S2 cells, whose PPAR levels were not increased by 
PPAR agonists. Our results indicated that forskolin’s lipo-
lytic effects were more subpopulation specific than its adipo-
genic effects.
Effects of fatty acids
Third, we studied the effects of seven fatty acids and the eicosa-
noid 15-d-PGJ2 (15-deoxy-12,14-prostaglandin J2; Fig. 5 d). 
Past studies found that saturated and monounsaturated fatty 
acids were more effective than polyunsaturated fatty acids in 
increasing LD accumulation during adipogenesis (Madsen et al., 
2005). However, polyunsaturated fatty acids and 15-d-PGJ2 
were demonstrated to affect PPAR’s transcriptional activities 
directly (Forman et al., 1997; Kliewer et al., 1997). We won-
dered how acute treatment with these fatty acids would affect 
adipogenesis at the subpopulation level.
At  the  population-averaged  level,  the  responses  to  the 
tested fatty acids could be divided into two major categories. The 
first category consisted of fatty acids with low saturation levels 
(16:0, 16:1, 18:1, 18:2, and 18:3) that increased the population-
averaged LD levels. At the subpopulation level, the increases of 
LD levels were mostly caused by enrichment of S4 cells and in-
creased average LD levels of S3 and S4 cells. Palmitic (16:0) 
and linoleic (18:2) acids also induced new subpopulations that 
had extremely high average LD levels (94- and 41-fold over qui-
escent cells). Most of the fatty acids in this category did not 
increase PPAR level at both the population-averaged and 
subpopulation levels. The only exception was oleic acid, which 
increased PPAR levels on S3 and S4 cells.
The second category consisted of polyunsaturated fatty 
acids with high saturation levels (20:4 and 20:5) and 15-d-PGJ2 
that did not increase the population-averaged LD level. These 
fatty acids increased the percentage of cells that had few and 
small LDs (S1). Interestingly, although these perturbations did 
not increase population-averaged PPAR levels, they signifi-
cantly increased the PPAR level of S4 cells (Fig. 5 d). In fact, 
for the fatty acids in our study, we found that their half-maximal 
inhibitory concentration values in a PPAR-binding competi-
tion assay (Kliewer et al., 1997; Xu et al., 1999) were highly 
correlated to their effects on S4-averaged PPAR levels (Fig. 5 e). 
Together, our results suggested that different categories of fatty 
acids affected the identified subpopulations differently.
Conclusions
Differentiating 3T3-L1 preadipocytes are highly heterogeneous 
in their cellular and lipid morphologies. Some aspects of this 
observed heterogeneity likely reflect the intrinsic stochasticity JCB • VOLUME 187 • NUMBER 3 • 2009   382
with 5% BSA in TBST for 2 h at room temperature, membranes were incu-
bated with the appropriate dilutions of primary antibodies, namely anti-
PPAR at 1:1,000, anti-HSL at 1:1,000 (Cell Signaling Technology), and 
anti-AdipoQ at 1:10,000 (provided by P.E. Scherer) overnight. After incu-
bation, the membrane was washed with TBST five times followed by incu-
bation with HRP-conjugated secondary antibody (1:10,000) in 5% BSA for 
1 h. The membranes were washed for 30 min after the incubation period. 
Target proteins were visualized by enhanced chemiluminescence. The Gel 
Analyzer function in ImageJ (version 1.41o; National Institutes of Health) 
was used to quantify the captured images of Western blots.
Fixed- and live cell imaging
For fixed-cell imaging, we used a 20× objective on an inverted fluores-
cence microscope (TE-2000; Nikon) equipped with a 12-bit charge- 
coupled device camera (CoolSNAP HQ; Photometrics) controlled by 
MetaMorph software (version 7.1; Universal Imaging). 16 images were ac-
quired for each imaging well. We subtracted background intensities from 
the images using the rolling ball algorithm in ImageJ software (version1.38l) 
and stitched the 16 images together using the TurboReg plugin (http://
bigwww.epfl.ch/thevenaz/turboreg). For live cell imaging, we used a 20× 
phase contrast objective on an inverted light microscope (TS-100; Nikon) 
equipped  with  a  12-bit  color  charge-coupled  device  camera  (DS-Fi1; 
Nikon) controlled by a control unit (DS-L1; Nikon). Two color images were 
taken per day (12 h apart) from D5 to 18. The color images were con-
verted into grayscale by averaging all of the color channels, and the inten-
sity values were automatically scaled by using the imadjust function in 
Matlab (version 2007a; Mathworks) with default parameters. Individual 
cells were manually tracked from the captured image sequences.
Cell categorization and quantification
All image and data analyses were performed using Matlab software. We 
applied a previously developed segmentation algorithm (Loo et al., 2007) 
to automatically identify the cellular and nuclear regions for each 3T3-L1 
cell. Although low marker staining levels tended to result in underestimation 
of cellular areas (Fig. S2 a), in general, estimated marker levels were still 
strongly and positively correlated to the “ground truth” (Fig. S2 b). Further-
more, subpopulation statistics were similar regardless of whether cellular 
regions were identified by the automated or manual segmentation proce-
dures (Fig. S2 c). Once automatically segmented, cells were manually cate-
gorized into one of the two mutually exclusive categories: quiescent and 
differentiating. Quiescent cells showed no sign of differentiation, as indi-
cated by a lack of visible PPAR and AdipoQ expressions and lipid accu-
mulations. The only significant staining on these cells was the DNA marker 
(Fig. 2 b, S0), and thus, these cells could be easily distinguished from other 
cells by their round cellular boundary around the nucleus. All nonquiescent 
cells were categorized as differentiating. We identified 500 differentiat-
ing cells per replicate per time point. During the categorization process, 
overlapping or badly segmented cells were also discarded from further 
analysis. After categorization, the average cellular or nuclear level of a 
marker was quantified by summing the intensity values from all pixels in the 
cellular  or  nuclear  region,  respectively,  and  dividing  the  resulting  total 
value with the corresponding number of pixels. Finally, each marker level 
was normalized by the median values measured from the quiescent cells as 
described in Results and discussion.
Data analysis
To identify subpopulations, cells were computationally pooled from all rep-
licates of D6, 9, and 12 (each day had three replicates) and were equally 
subsampled by 1:9. A standard expectation maximization algorithm (ver-
sion 3.2; NetLab Toolbox; http://www.ncrg.aston.ac.uk/netlab/index 
.php) was applied to the resulting cell samples to determine the optimum 
Gaussian mixture models (Slack et al., 2008). We tried 2–10 clusters   
(Fig. S1 a). To identify new phenotypes, a standard one-dimensional sup-
port vector machine (version 2.88; libsvm Toolbox; http://www.csie.ntu 
.edu.tw/~cjlin/libsvm) was used (Schölkopf et al., 2001). We fixed the 
 parameter to be 0.001 and used a fivefold cross-validation to determine 
the optimum value of the  parameter that gave us 99% training classifica-
tion accuracy. For our dataset, the optimum  was found to be 2.96 × 
10
3. To perform hierarchical clustering of Fig. 4, we used the clustergram 
function of Matlab and set the parameters to be cosine distance and single 
linkage.  Before  clustering,  the  subpopulation-averaged  level  for  each 
marker was first computed, subtracted by one (as the minimum possible 
value was onefold), and divided by the maximum value across all subpop-
ulations. All statistical analyses were performed using the Statistics Toolbox 
(version 6.0) in Matlab.
scintillation tubes, and their sodium salts were precipitated with 5 M NaOH 
solution. After ethanol was blow dried with a gentle argon stream, the so-
dium salts of FFAs were reconstituted with sodium chloride at 0.9% wt/vol 
and 24% BSA (fatty acid free) by stirring continuously at room temperature. 
The final concentration of BSA was 10% in 0.15 M NaCl solution. The BSA-
bound FFA solutions were aliquoted in microtubes evacuated with argon 
and frozen at 20°C. We note that under control conditions, S2–4 had 
lower PPAR levels than our earlier time course and molecular-profiling re-
sults (Fig. 5 c [black bars] vs. Figs. 2 e and 4 b), potentially as a result of the 
presence of DMSO and BSA. However, there was no significant change in 
the AdipoQ and LD levels under the control conditions (Fig. 2 c vs. Fig. 5 b 
[left]), and thus, the original subpopulation model was still applicable.
For the following steps of medium changes, drug applications, and 
vital  dye  staining,  a  Laboratory  Automation  Workstation  (Biomek  FX; 
Beckman Coulter) was used. Maintenance medium in the imaging plate 
was replaced with 50 µl of defined medium 16 h after the cells were 
transferred to imaging plates, and 25 µl freshly prepared drug working 
stocks (diluted with defined medium) were dispensed onto the plates and 
incubated for 24 h. The final concentrations of DMSO and BSA in the 
medium were compensated to 0.3% and 0.5% wt/vol, respectively, for 
control and drug-treated sets. The final concentrations of all perturbations 
can be found in Fig. 5 d.
Immunofluorescence staining
4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene 
(BODIPY 493/503; Invitrogen) was used to stain LDs at the concentration 
of 1 µg/liter in Dulbecco’s minimum essential medium. After a 30-min incu-
bation, cells were washed once with Dulbecco’s minimum essential medium 
and immediately fixed with 4% PFA (Electron Microscopy Sciences) in PBS 
for 15 min at room temperature. The PFA solution was kept warm at 37°C 
until being added to the plate with an automatic microplate dispenser 
(Matrix WellMate; Thermo Fisher Scientific). At the end of incubation, the 
fixative was quickly flicked out and quenched with 50 mM ammonium 
chloride. After a 10-min incubation, the cell plate was gently rinsed three 
times with TBS using a plate washer (ELX405; BioTek).
The  following  primary  antibodies  were  used:  anti-HSL,  anti-pHSL 
(Ser565), anti-PPAR, anti-C/EBP (rabbit polyclonal; Cell Signaling Tech-
nology), antiperilipin (rabbit polyclonal; Abcam), and anti-AdipoQ (mouse 
monoclonal; provided by P.E. Scherer, University of Texas Southwestern 
Medical Center, Dallas, TX). The following secondary antibodies were used: 
Alexa Fluor 647–conjugated anti–rabbit and Alexa Fluor 546–conjugated 
anti–mouse immunoglobulin (Invitrogen). Fixed 3T3-L1 cells were permea-
bilized with 0.2% Triton X-100 in TBS for 5 min and washed twice with TBS 
on a plate washer (ELX405). Blocking solution of 5% BSA in TBST was 
added for a 1-h incubation and replaced with different primary antibody 
combinations (one from mouse and one from rabbit) diluted in blocking so-
lution. The plates were tightly sealed with Parafilm and incubated at 4°C 
overnight. The primary antibodies were thoroughly rinsed off three times 
with TBS and once with blocking buffer. Each wash took at least a 10-min 
incubation time. The fixed cells were further incubated with fluorescence-
labeled  secondary  antibodies  for  1  h  and  washed  three  times  with 
TBST. Finally, 2 µg/ml Hoechst (Invitrogen) was introduced to highlight 
nuclei. After two TBS washes, the plates were preserved in 0.1% freshly 
prepared sodium azide at 4°C.
Subcellular protein fractionation
A subcellular protein fractionation kit (Thermo Fisher Scientific) was used to 
fractionate proteins into nuclear and cytoplasmic fractions using the manu-
facturer’s protocol. The supernatants obtained from the cytoplasmic, mem-
brane,  and  cytoskeletal  fractions  were  pooled  together  to  form  the 
nonnuclear  fraction.  The  nuclear  fraction  was  saved  separately.  Next, 
chilled acetone was added at four times the volume of the supernatant for 
each of the nuclear and nonnuclear fractions and incubated at 20°C for 
1 h. After incubation, the fractions were centrifuged at 16,000 g for 10 min 
to precipitate the proteins. The supernatant was discarded, and the pellet 
was air dried. To each of the pellets, 100 µl Tris buffer, pH 7.0, was added. 
Protein concentration was estimated, and the samples were boiled with 
2× SDS sample loading buffer.
Western blot analyses
A Bradford protein assay (Protein Assay kit; Bio-Rad Laboratories) was 
used to quantify the concentrations of proteins presented in the samples 
collected from each day of differentiation. 10 µg of protein was loaded in 
a 4–20% gradient SDS polyacrylamide gel, subjected to electrophoresis 
for 2 h, and transferred to Immobilon-P membrane (Millipore). After blocking 383 Heterogeneity in 3T3-L1 adipogenesis • Loo et al.
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